Caveolin Interaction with Protein Kinase C
ISOENZYME-DEPENDENT REGULATION OF KINASE ACTIVITY BY THE CAVEOLIN SCAFFOLDING DOMAIN PEPTIDE*
- Naoki Oka,
- Manabu Yamamoto,
- Carsten Schwencke,
- Jun-ichi Kawabe,
- Toshiaki Ebina,
- Shigeo Ohno‡,
- Jacques Couet§,
- Michael P. Lisanti§¶ and
- Yoshihiro Ishikawa‖
- From the Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212,‡Department of Biochemistry, Yokohama City University, Yokohama, Japan, and §Department of Molecular Pharmacology, Albert Einstein Medical College, New York, New York 10461
Abstract
Caveolar localization of protein kinase C and the regulation of caveolar function by protein kinase C are well known. This study was undertaken to examine whether caveolin subtypes interact with various protein kinase C isoenzymes using the caveolin scaffolding domain peptide. When protein kinase C-α, -ε, and -ζ were overexpressed in COS cells followed by subcellular fractionation using the sucrose gradient method, all the isoenzymes (α, ε, and ζ) were detected in the same fraction as caveolin. The scaffolding domain peptide of caveolin-1 and -3, but not -2, inhibited the kinase activity and autophosphorylation of protein kinase C-α and -ζ, but not of protein kinase C-ε, overexpressed in insect cells. Truncation mutation studies of the caveolin-1 and -3 peptides demonstrated that a minimum of 16 or 14 amino acid residues of the peptide were required for the inhibition or direct binding of protein kinase C. Thus, the caveolin peptide physically interacted with protein kinase C and regulated its function. Further, this regulation occurred in a protein kinase C isoenzyme-dependent manner. Our results may provide a new mechanism regarding the regulation of protein kinase C isoenzyme activity and the molecular interaction of protein kinase C with its putative binding proteins.
Footnotes
-
↵* This study was supported in part by United States Public Health Service Grants HL59139 and HL54895.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵¶ Supported by the United States Public Health Service Grant GM 50443.
-
↵‖ To whom correspondence should be addressed. Tel.: 412-359-6745; Fax: 412-359-4367; E-mail: yishikaw{at}pgh.auhs.edu.
-
↵1 The abbreviations used are: PKC, protein kinase C; PDBu, phorbol 12,13-dibutyrate; PAGE, polyacrylamide gel electrophoresis.
-
- Received September 4, 1997.
- Revision received October 13, 1997.











